UNIVERSITE LIBRE DE BRUXELLES

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
G01F MEASURING VOLUME, VOLUME FLOW, MASS FLOW, OR LIQUID LEVEL; METERING BY VOLUME 158
 
  
 
G01L MEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE 155

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0097,295 METHOD FOR DETERMINING SUSPENDED MATTER LOADS CONCENTRATIONS IN A LIQUIDDec 16, 16Apr 06, 17[G01L, G01N, G01F]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9890431 detection in bloodNov 15, 11Feb 13, 18[C12Q, C12P]
9828644 BACH2 repression in cellsOct 12, 11Nov 28, 17[C12Q, C12N]
9181265 Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agentsDec 22, 11Nov 10, 15[A61K, C07D]
9168247 Beta carboline derivatives useful in the treatment of proliferative disordersJun 24, 11Oct 27, 15[A61K, C07D]
9119817 Wild-type apolipoprotein L-I for use in the prevention of kidney diseasesFeb 17, 12Sep 01, 15[A61K, A61P]
8337827 Method for osteogenic differentiation of bone marrow stem cells (BMSC) and uses thereofFeb 16, 07Dec 25, 12[A61K, A01N]
7964575 Use of a galectin-1-targeted RNAi-based approach for the treatment of cancerMar 09, 06Jun 21, 11[A61K, C07H, C12N]
7595186 Cytotoxin-based biological containmentAug 10, 07Sep 29, 09[C12N]
7183097 Cytotoxin-based biological containmentMay 07, 99Feb 27, 07[C12N]
6635484 Standard used in diagnostic and/or quantification testsDec 07, 99Oct 21, 03[G01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0132,590 Active Corrosion Protection CoatingsAbandonedMay 07, 13May 14, 15[B05D, C23F]
2013/0338,937 METHOD FOR DETERMINING SUSPENDED MATTER LOADS CONCENTRATIONS IN A LIQUIDAbandonedMar 09, 12Dec 19, 13[G01N]
8580496 Method and kit for the detection of genes associated with PIK3CA mutation and involved in PI3K/AKT pathway activation in the ER-postitive and HER2-positive subtypes with clinical implicationsExpiredAug 20, 10Nov 12, 13[C12Q]
2013/0296,328 EPIGENETIC PORTRAITS OF HUMAN BREAST CANCERSAbandonedJan 20, 12Nov 07, 13[C12Q]
2013/0224,285 ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOFAbandonedOct 13, 11Aug 29, 13[G01N, C07K]
2013/0053,347 PRO-DRUGS OF AMARYLLIDACEAE ISOCARBOSTYRIL PRODUCTS AND THEIR USE AGAINST BRAIN TUMORSAbandonedMay 03, 10Feb 28, 13[A61K, C07F, G01N, A61P]
2010/0330,044 MESP1 AS A MASTER REGULATOR OF MULTIPOTENT CARDIOVASCULAR PROGENITOR SPECIFICATION AND USES THEREOFAbandonedJun 30, 09Dec 30, 10[A61K]
2010/0202,071 DEFORMABLE MIRRORAbandonedJan 11, 10Aug 12, 10[B23P, G02B]
2009/0228,012 SURGICAL BORING TOOL SETAbandonedFeb 16, 06Sep 10, 09[A61B]
2009/0162,333 PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASESAbandonedMay 25, 07Jun 25, 09[A61K, A61P]
7022892 Non-human genetically modified mammal lacking the alpha-fetoproteinExpiredJul 11, 00Apr 04, 06[G01N]
2005/0008,662 Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compoundsAbandonedJul 27, 04Jan 13, 05[A61K]
6830928 Plant micropropagation and germplasm storageExpiredNov 24, 99Dec 14, 04[C12N]
6535276 Method for measuring the velocity of particles in a fluid medium in motionExpiredJul 12, 01Mar 18, 03[G01P, G03H]
2002/0155,161 Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compoundsAbandonedDec 28, 01Oct 24, 02[A61K]
2002/0141,973 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseAbandonedSep 10, 01Oct 03, 02[A61K]
2001/0012,632 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseAbandonedMar 09, 01Aug 09, 01[A61K, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.